1) DEPEN. Departamento Penitenciário Nacional. Levantamento Nacional de
Informacões Penitenciárias INFOPEN–Dezembro de 2015. Ministerio da
Justica. p. 7–10, 2015. < https://www.justica.gov.br/news/ha-726-712-pessoas-
presas-no-brasil/relatorio_2015_dezembro.pdf >.
2) ICPS. International Centre for Prison Studies. World Prision Brief. Kings
College London, 2019. < http://www.prisonstudies.org/highest-to-lowest/prison-
population-total?field_region_taxonomy_tid=All >.
3) Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, Gavani A, Kinner SA, et al.
Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and
detainees. The Lancet. 2016; 388(10049): 1089–1102.
4) BRASIL. Ministerio da Justica. Censo das unidades prisionais e dados
agregados. 24 de janeiro de 2016. http://www.justica.gov.br/seus-
direitos/politica-penal/transparencia-institucional/estatisticasprisional/base-de-
dados-infopen-csv.csv . Acessed in: april 15, 2017.
5) Kamarulzaman A, Reid SE, Schwitters A, Wiessing L, El-Bassel N, Dolan K, et
al. Prevention of transmisión of HIV, hepatitis B virus, hepatitis C virus, and
tuberculosis in prisoners. Lancet. 2016; 388 (10049): 1115–1126.
6) Kretzer IF, Livramento A, Cunha J, Gonc¸alves S, Tosin I, Spada C, et al.
Hepatitis C Worldwide and in Brazil: Silent Epidemic—Data on Disease
including Incidence, Transmission, Prevention, and Treatment. The Scientific
World Journal. 2014; 2014: 1–10. https://www.ncbi.nlm.nih.gov/pubmed/
25013871.
7) Araújo-Mariz C, Lopes EP, Ximenes RA, Lacerda HR, Miranda-Filho DB,
Montarroyos UR, et al. Serological markers of hepatitis B and C in patients with
HIV/AIDS and active tuberculosis. J Med Virol. 2016; 88(6): 996–1002.
8) Gheorghe L, Csiki IE, Iacob S, Gheorghe C. The prevalence and risk factors of
hepatitis B virus infection in an adult population in Romania: a nationwide
survey. Eur J Gastroenterol Hepatol 2013; 25:56–64.
9) Mutagoma M, Remera E, Sebuhoro D, Kanters S, Riedel DJ, Nsanzimana S.
The Prevalence of Syphilis Infection and Its Associated Factors in the General
Population of Rwanda: A National Household-Based Survey, 2016. J Sex
Transm Dis 2016; 2016:4980417.
10) Fernandes RM, Cary M, Duarte G, Jesus G, Alarcão J, Torre C, et al.
Effectiveness of needle and syringe Programmes in people who inject drugs–An
overview of systematic reviews. BMC Public Health. 2017; 17(1):309.
11) Heijnen M, Mumtaz GR, Abu-Raddad LJ. Status of HIV and hepatitis C virus
infections among prisoners in the Middle East and North Africa: review and
synthesis. J Int AIDS Soc. 2016 May 27; 19(1):20873.
12) Almasio PL, Babudieri S, Barbarini G, Brunetto M, Conte D, Dentico P, et al.
Recommendations for the prevention, diagnosis, and treatment of chronic
hepatitis B and C in special population groups (migrants, intravenous drug users
and prison inmates). Dig Liver Dis. 2011; 43(8): 589–595.
13) Lederer DJ, Bell SC, Branson RD, Chalmers JD, Marshall R, Maslove DM, et
al. Controlo of Confounding and Reporting of Results in Causal Inference
Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical
Care Journals. Ann Am Thorac Soc. 2019 Jan; 16(1):22–28.
Dr. Omar Angel Gabrielli
Asesor Médico – Instituto de Estudios Criminológicos